|
|
|
|
|
|
|
|
Clinical trials test new methods to treat specific types of cancer through carefully defined research studies in humans. This can mean evaluating a new drug or a new combination of existing drugs. Some trials test the comparative effectiveness of new methods to old ones. An "investigational treatment" is a therapy being studied in a clinical trial.
In order for a new therapy to be accepted as a standard form of treatment, it must undergo rigorous testing, first in animals and then under very carefully controlled environments in humans. Participation is completely voluntary and no one knows in advance what the outcome might be, including side effects or overall success. If you make the decision to join a clinical trial, all of the trial details will be explained to you and you will be asked to sign a form indicating "informed consent." However, you may leave the study at any time after the trial begins even after signing the form.
Ask your oncologist about any clinical trials that might be beneficial in your fight against your cancer. Trials are often funded by the National Cancer Institute through its designated cancer centers or other cooperative networks. For additional information from the NCI, visit its Web site at cancertrials.nci.nih.gov or call (800) 4-CANCER.
Lymphoma.com is copyright © 1996-2010 WebMagic, Inc. and is designed, maintained and sponsored by WebMagic, Inc.
Lymphoma.com™ is our trademark. All rights reserved.
No portion of this site may be reproduced in any form without express written permission.
